Key Slides on Essential Strategies for Eliminating HCV Among Persons With Current or Recent Injection Drug Use

This downloadable slideset provides an in-depth review of strategies for overcoming barriers to the elimination of HCV infection among persons who inject drugs.
Arthur Kim, MD
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Jeannette M. Tetrault, MD, FACP, FASAM
Format: Microsoft PowerPoint (.ppt)
File Size: 1.61 MB
Released: April 2, 2019

Acknowledgements

Jointly provided by

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Endorsed by
This activity is supported by independent educational grants from
AbbVie
Gilead Sciences

Related Content

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Expert selections of the most important viral hepatitis data from EASL 2020, including HCV elimination and HCV and HBV treatment, provided by CCO

Stefan Zeuzem, MD Released: September 8, 2020

Downloadable PDF resource from CCO on opioid use disorder treatment essentials for hepatologists and ID specialists managing HCV and/or HIV infection

Jenna Butner, MD Released: May 7, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue